Opella: Sanofi and CD&R Sign Share Purchase Agreement for 50% Stake
Deal News | Feb 19, 2025 | Clayton, Dubilier & Rice, Inc.
Sanofi and Clayton, Dubilier & Rice (CD&R) have signed a share purchase agreement for CD&R to acquire a 50% controlling stake in Opella. The transaction, which is expected to close in Q2 2025 at the earliest pending regulatory approvals, will also see Bpifrance take a minority 2% share, with Sanofi retaining significant ownership. Sanofi, a major global healthcare company, is committed to transforming the practice of medicine worldwide. The agreement adheres to previous transaction terms and highlights the potential for strategic benefits provided regulatory approvals and other conditions are successfully met.
Sectors
- Healthcare
- Private Equity
- Pharmaceuticals
Geography
- France – Sanofi is a French company, and Bpifrance is the French public investment bank.
- United States – CD&R is a US-based private equity firm.
Industry
- Healthcare – Relevant as Sanofi is a global healthcare company providing treatment and vaccine solutions.
- Private Equity – CD&R is a private equity firm acquiring a controlling stake in Opella.
- Pharmaceuticals – Sanofi is involved in the pharmaceutical industry, impacting its operations and the transaction.
Financials
- 2% – Bpifrance's expected minority stake percentage in Opella.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Opella | Target Company | Company | Opella is the company in which CD&R is acquiring a 50% controlling stake from Sanofi. |
| Sanofi | Selling Company | Company | Sanofi is selling a 50% controlling stake in Opella but retains significant ownership. |
| Clayton, Dubilier & Rice (CD&R) | Bidding Company | Company | CD&R is acquiring a 50% controlling stake in Opella. |
| Bpifrance | Other Company | Company | Bpifrance will participate as a minority shareholder in Opella. |